Standard BioTools - 14 Year Stock Price History | LAB
Historical daily share price chart and data for Standard BioTools since 2011 adjusted for splits and dividends. The latest closing stock price for Standard BioTools as of April 24, 2025 is 1.23.
- The all-time high Standard BioTools stock closing price was 48.89 on March 05, 2014.
- The Standard BioTools 52-week high stock price is 2.74, which is 122.8% above the current share price.
- The Standard BioTools 52-week low stock price is 0.97, which is 21.1% below the current share price.
- The average Standard BioTools stock price for the last 52 weeks is 1.81.
| Standard BioTools Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 1.3466 | 1.7500 | 2.0600 | 1.0100 | 1.2300 | -29.71% |
| 2024 | 2.1658 | 2.2200 | 2.9200 | 1.4200 | 1.7500 | -20.81% |
| 2023 | 2.1764 | 1.3000 | 3.0500 | 1.3000 | 2.2100 | 88.89% |
| 2022 | 2.1587 | 3.7200 | 3.9900 | 0.9300 | 1.1700 | -70.15% |
| 2021 | 5.5256 | 6.1700 | 7.4100 | 3.6300 | 3.9200 | -34.67% |
| 2020 | 5.0807 | 3.4900 | 11.4300 | 1.2400 | 6.0000 | 72.41% |
| 2019 | 8.6295 | 8.5900 | 14.3600 | 2.3000 | 3.4800 | -59.63% |
| 2018 | 6.7886 | 6.2300 | 8.8300 | 4.8600 | 8.6200 | 46.35% |
| 2017 | 5.1843 | 7.5900 | 8.3300 | 2.7100 | 5.8900 | -19.09% |
| 2016 | 8.0352 | 10.1200 | 10.9100 | 4.3400 | 7.2800 | -32.65% |
| 2015 | 23.9509 | 33.6100 | 45.5400 | 7.3800 | 10.8100 | -67.95% |
| 2014 | 32.9927 | 36.8000 | 48.8900 | 22.0600 | 33.7300 | -11.89% |
| 2013 | 20.9563 | 14.5000 | 39.3700 | 14.2700 | 38.2800 | 167.51% |
| 2012 | 14.7265 | 13.3200 | 17.1500 | 12.6000 | 14.3100 | 8.74% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.440B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Enovis (ENOV) | United States | $1.825B | 11.29 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |